Company Filing History:
Years Active: 2011-2014
Title: John McNeil McGill: Innovator in Oral Delivery Systems
Introduction
John McNeil McGill is a notable inventor based in Greenwood, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral delivery systems for peptide compounds. With a total of 4 patents to his name, McGill's work is paving the way for advancements in drug delivery methods.
Latest Patents
Among his latest patents, McGill has developed compounds, methods, and formulations for the oral delivery of glucagon-like peptide (GLP-1) compounds and melanocortin-4 receptor (MC4) agonist peptides. These inventions focus on novel approaches that enhance the effectiveness of peptide-based therapies, making them more accessible and easier to administer.
Career Highlights
McGill is currently associated with Emisphere Technologies, Inc., where he continues to innovate in the realm of drug delivery systems. His work is instrumental in bridging the gap between complex peptide therapies and patient-friendly administration methods.
Collaborations
Some of his notable coworkers include Mohammed Amin Khan and Bryan Edward Jones, who contribute to the collaborative efforts in research and development at Emisphere Technologies, Inc.
Conclusion
John McNeil McGill's contributions to the field of oral delivery systems for peptide compounds highlight his role as a leading inventor in the pharmaceutical industry. His innovative approaches are set to transform how peptide therapies are delivered to patients, ensuring better health outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.